Avantor (NYSE:AVTR) Earns Neutral Rating from Analysts at UBS Group

Equities researchers at UBS Group started coverage on shares of Avantor (NYSE:AVTR) in a note issued to investors on Wednesday, Briefing.com reports. The brokerage set a “neutral” rating and a $16.00 price target on the stock. UBS Group’s target price points to a potential upside of 4.71% from the company’s current price.

AVTR has been the subject of several other reports. Deutsche Bank Aktiengesellschaft restated a “hold” rating and issued a $13.00 price objective on shares of Avantor in a research note on Thursday, July 30th. Jefferies Financial Group raised Avantor from an “underperform” rating to a “hold” rating and set a $13.00 price target for the company in a report on Wednesday, July 29th. TD Cowen restated a “hold” rating on shares of Avantor in a research report on Wednesday, July 15th. Wells Fargo & Company raised their price objective on Avantor from $14.00 to $16.00 and gave the stock an “overweight” rating in a research note on Thursday, July 30th. Finally, Wall Street Zen raised Avantor from a “hold” rating to a “buy” rating in a research report on Saturday, June 27th. Two analysts have rated the stock with a Buy rating, fifteen have given a Hold rating and one has given a Sell rating to the stock. According to data from MarketBeat.com, the company currently has a consensus rating of “Hold” and an average target price of $12.47.

Avantor Price Performance

Shares of NYSE:AVTR opened at $15.28 on Wednesday. The company has a quick ratio of 1.18, a current ratio of 1.78 and a debt-to-equity ratio of 0.65. The stock has a market capitalization of $10.34 billion, a PE ratio of -18.19, a price-to-earnings-growth ratio of 11.30 and a beta of 0.89. The firm’s 50 day moving average price is $12.82 and its 200-day moving average price is $10.02. Avantor has a twelve month low of $7.26 and a twelve month high of $15.93.

Avantor (NYSE:AVTR) last announced its earnings results on Wednesday, July 29th. The company reported $0.21 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.19 by $0.02. Avantor had a negative net margin of 8.81% and a positive return on equity of 9.92%. The company had revenue of $1.69 billion during the quarter, compared to analyst estimates of $1.61 billion. During the same period in the previous year, the business posted $0.24 earnings per share. The firm’s quarterly revenue was up .5% compared to the same quarter last year. Avantor has set its FY 2026 guidance at 0.800-0.830 EPS. Equities research analysts expect that Avantor will post 0.81 EPS for the current year.

Institutional Inflows and Outflows

Large investors have recently added to or reduced their stakes in the business. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. grew its holdings in Avantor by 28.1% during the 3rd quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 4,123 shares of the company’s stock valued at $49,000 after buying an additional 905 shares in the last quarter. Osaic Holdings Inc. lifted its holdings in shares of Avantor by 60.9% in the second quarter. Osaic Holdings Inc. now owns 2,810 shares of the company’s stock worth $38,000 after buying an additional 1,064 shares in the last quarter. UMB Bank n.a. lifted its holdings in shares of Avantor by 17.6% in the fourth quarter. UMB Bank n.a. now owns 7,371 shares of the company’s stock worth $84,000 after buying an additional 1,101 shares in the last quarter. EverSource Wealth Advisors LLC boosted its position in shares of Avantor by 119.1% during the second quarter. EverSource Wealth Advisors LLC now owns 2,187 shares of the company’s stock worth $29,000 after acquiring an additional 1,189 shares during the last quarter. Finally, Public Employees Retirement System of Ohio grew its stake in Avantor by 0.6% during the third quarter. Public Employees Retirement System of Ohio now owns 206,386 shares of the company’s stock valued at $2,576,000 after acquiring an additional 1,279 shares in the last quarter. 95.08% of the stock is owned by hedge funds and other institutional investors.

Avantor Company Profile

Avantor, Inc (NYSE:AVTR) is a global provider of mission-critical products and services to customers in the biopharma, healthcare, education & government, and advanced technologies & applied materials industries. The company delivers essential solutions that support research, development, production and safety applications. Its product portfolio spans from high-purity chemicals and reagents to biologics and cell culture media, as well as lab equipment, consumables and custom manufacturing services.

Avantor’s offerings are organized across two primary segments.